Patients with anxiety spectrum disorders are a highly heterogeneous group, requiring new therapeutic strategies and individualized treatment monitoring. Today, there is a growing interest for implementing biological approaches to clinical practice in psychiatry. Quantitative EEG is an excellent tool in this regard, though it has been widely underestimated when compared to recent neuroimaging techniques. In this case series, we presented four cases with a different diagnosis of anxiety spectrum disorder and evaluated their qEEG changes before and after the treatment. In addition, we also calculated the so-called EEG cordance values as an index of cerebral perfusion and cingulate cortex activity. According to the results, there appears to be an increase in the frontal beta and theta band in our cases, which has responded to treatment. In regards to the cordance values, we found that there was a reduction in the prefrontal regions up to %38 percent following the treatment. Based on previous studies, this may also indirectly suggest reduction in the cingulate cortex activity. The possible implications of these findings were discussed. Taken together, this case series highlighted the potential use of qEEG power values, normative z-scores and cordance values in treatment response monitoring of anxiety spectrum disorders.
Relationship between impulsivity and plasma uric acid levels in patients with substance use disorders Objective: Impulsivity is an important neurobiological process that contributes to individual differences in substance use disorder vulnerability. Uric acid has been mentioned to be telated to some psychiatric disorders characterized by impulsivity. No other study has yet examined the relationship between UA plasma concentration and impulsivity in patients with substance use disorders. Methods: Eighty patients diagnosed with substance use disorders and eighty healthy controls were included. A protein-rich diet was given to all subjects for one week. Blood samples were obtained and plasma uric acid levels were recorded as in mg/dl after being centrifuged for 15 min at 3000 X g and kept at-80°C. Impulsivity was evaluated using the Turkish version of Barrat Impulsivity Scale (BIS). Results: The mean uric acid concentrations (t/χ 2 =3.3; p<0.05) were significantly higher in the patients with substance use disorders compared to the healthy control group. Additionally, total BIS scores (t/χ 2 =2.4; p<0.05), Attentional Impulsiveness scores (t/χ 2 =2.1; p<0.05), and Motor Impulsiveness scores (t/χ 2 =2.6; p<0.05) were statistically significantly higher in the patients with substance use disorder. There was a negative mild, statistically significant correlation between UA plasma levels in the patients with substance use disorder and total BIS scores (r=-0.278; p<0.05), and Motor Impulsiveness subscales scores (r=-0.302; p<0.01). Multiple linear regression analysis revealed that plasma UA levels were found to be statistically significantly associated with the Motor Impulsiveness scores in the patients with substance use disorder (p=0.007). Conclusions: This preliminary study is the first study that explores how uric acid levels were associated with impulsivity in patients with substance use disorder. Further studies with larger sample size are needed to tease out confounding factors and replicate our findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.